Agenus Inc
AGEN
NASDAQ
Biotechnology
$7.32
USD
+0.32 (+4.57%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $315.14M
Volume 1.3M
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
SCTX | Scribe Therapeutics Inc | - | - | - | - | |
ABEO | Abeona Therapeutics Inc | $363.91M | 5.50 | - | - | |
GALT | Galectin Therapeutics Inc | $356.00M | - | - | - | |
TLSI | TriSalus Life Sciences Inc | $351.59M | - | +39.6% | - | |
SABS | SAB Biotherapeutics Inc | $345.75M | 26.05 | - | - | |
LYEL | Lyell Immunopharma Inc | $336.70M | - | -52.3% | - | |
IMRX | Immuneering Corp | $336.43M | - | - | - | |
IKT | Inhibikase Therapeutics Inc | $336.28M | - | - | - | |
AGEN | Agenus Inc | $315.14M | 4.88 | +24.5% | - | |
VNDA | Vanda Pharmaceuticals Inc | $304.35M | - | +8.2% | - | |
CAMP | CAMP4 Therapeutics Corp | $219.13M | - | +5.6% | - |
Top Peer by Growth
TriSalus Life Sciences Inc
+39.6% YoY Revenue
Lowest P/E Ratio
Agenus Inc
4.88x P/E
Best 1-Year Return
CAMP4 Therapeutics Corp
+228.3% Return